# Saxenda litigation

> Educational mass tort overview from DrugsMonitor.com. Not legal or medical advice.

**Canonical URL:** https://drugsmonitor.com/case/saxenda-liraglutide-lawsuit
**Last updated:** 2026-06-11

## Key facts

- **Matter:** Saxenda (liraglutide)
- **Status:** Discovery Phase
- **Scope:** United States — national overview
- **Drug safety page:** https://drugsmonitor.com/drug-info/saxenda-liraglutide-lawsuit

## Overview

### Clinical context

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes.

### Litigation context

Often analyzed alongside MDL No. 3094 themes; confirm how your court treats product-specific defenses.

---

*DrugsMonitor.com is not a law firm. For medical decisions consult a licensed clinician; for legal decisions consult a qualified attorney.*